Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Potere Health MD vs Revel RX

By GLP-1 ScorecardUpdated

Potere Health MD
Site position #88

Lower grade

Revel RX
Site position #49

Higher grade

Score comparison

Revel RX has the higher recorded score — 77.3/100 to 72.5/100.

Revel RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Revel RX is a Michigan-based telehealth weight-loss platform offering compounded semaglutide at $89/month and compounded tirzepatide at $155/month — flat-rate at every dose tier.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueRevel RX +11
85
96
Dose & formulationRevel RX +8
64
72
Clinical oversightPotere Health MD +3
87
84
Labs & monitoringPotere Health MD +1
54
53
FulfillmentRevel RX +14
67
81
Contract termsPotere Health MD +6
61
55
Potere Health MD · top barRevel RX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricPotere Health MDRevel RX
WeighScore72.5/10077.3/100
GradeCC+
Site position#88#49
Semaglutide$80/mo (starting dose, compounded)$89/mo (all doses, compounded)
Tirzepatide$135/mo (starting dose, compounded)$155/mo (all doses, compounded)
Coverage1 stateCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Potere Health MD

Site position #88 · C

Strengths

  • Low starting pricing (about $80-$135/month) with no subscription lock-in
  • Physician-led by a named MD, not automated messaging
  • Third-party COA and LegitScript-certified pharmacy
  • Both telehealth and in-person Utah visits with fast scheduling

What to consider

  • Available in Utah only — a St George clinic offering telehealth within the state, not a national service
  • The per-vial price is fixed, so the monthly cost rises steeply with the dose: the provider's own table runs about $20/mo at 0.25 mg, $80/mo at 1.0 mg and about $199/mo at 2.5 mg
  • Medication is bought per vial up front rather than on a subscription, so there is no monthly rate to compare directly against a subscription program
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Revel RX

Site position #49 · C+

Strengths

  • Industry-low flat pricing: $89/mo for compounded semaglutide and $155/mo for tirzepatide at every dose
  • LegitScript verified and BBB accredited with an A+ rating — above-average trust signals for a compounded platform
  • Named pharmacy partners: Manifest Pharmacy and Red Rock Home Pharmacy (503A + 503B facilities)
  • Free overnight cold shipping included; no hidden fees or dose-based price increases
  • Clinical review by MD Integrations, an independent medical group, before any prescription is issued

What to consider

  • States served are not publicly listed; eligible states requires completing intake to confirm coverage
  • No labs, coaching, or ongoing health support disclosed in any public materials
  • Compounded medications are not FDA-approved (site discloses this)
  • Newer brand with limited public patient reviews or Trustpilot rating
  • Pharmacy partners named but no accreditation details (PCAB, 503B cGMP) published on the site

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard